These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21394111)

  • 1. Effect of expression of adenine phosphoribosyltransferase on the in vivo anti-tumor activity of prodrugs activated by E. coli purine nucleoside phosphorylase.
    Parker WB; Allan PW; Waud WR; Hong JS; Sorscher EJ
    Cancer Gene Ther; 2011 Jun; 18(6):390-8. PubMed ID: 21394111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity of 2-fluoro-2'-deoxyadenosine against tumors that express Escherichia coli purine nucleoside phosphorylase.
    Parker WB; Allan PW; Hassan AE; Secrist JA; Sorscher EJ; Waud WR
    Cancer Gene Ther; 2003 Jan; 10(1):23-9. PubMed ID: 12489025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo antitumor activity of intratumoral fludarabine phosphate in refractory tumors expressing E. coli purine nucleoside phosphorylase.
    Sorscher EJ; Hong JS; Allan PW; Waud WR; Parker WB
    Cancer Chemother Pharmacol; 2012 Aug; 70(2):321-9. PubMed ID: 22760227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo gene therapy of cancer with E. coli purine nucleoside phosphorylase.
    Parker WB; King SA; Allan PW; Bennett LL; Secrist JA; Montgomery JA; Gilbert KS; Waud WR; Wells AH; Gillespie GY; Sorscher EJ
    Hum Gene Ther; 1997 Sep; 8(14):1637-44. PubMed ID: 9322865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excellent in vivo bystander activity of fludarabine phosphate against human glioma xenografts that express the escherichia coli purine nucleoside phosphorylase gene.
    Hong JS; Waud WR; Levasseur DN; Townes TM; Wen H; McPherson SA; Moore BA; Bebok Z; Allan PW; Secrist JA; Parker WB; Sorscher EJ
    Cancer Res; 2004 Sep; 64(18):6610-5. PubMed ID: 15374975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 6-Methylpurine derived sugar modified nucleosides: Synthesis and in vivo antitumor activity in D54 tumor expressing M64V-Escherichia coli purine nucleoside phosphorylase.
    Hassan AEA; Abou-Elkhair RAI; Parker WB; Allan PW; Secrist JA
    Eur J Med Chem; 2016 Jan; 108():616-622. PubMed ID: 26724729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell to cell contact is not required for bystander cell killing by Escherichia coli purine nucleoside phosphorylase.
    Hughes BW; King SA; Allan PW; Parker WB; Sorscher EJ
    J Biol Chem; 1998 Jan; 273(4):2322-8. PubMed ID: 9442077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bystander killing of melanoma cells using the human tyrosinase promoter to express the Escherichia coli purine nucleoside phosphorylase gene.
    Hughes BW; Wells AH; Bebok Z; Gadi VK; Garver RI; Parker WB; Sorscher EJ
    Cancer Res; 1995 Aug; 55(15):3339-45. PubMed ID: 7614469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo sensitization of ovarian tumors to chemotherapy by expression of E. coli purine nucleoside phosphorylase in a small fraction of cells.
    Gadi VK; Alexander SD; Kudlow JE; Allan P; Parker WB; Sorscher EJ
    Gene Ther; 2000 Oct; 7(20):1738-43. PubMed ID: 11083495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic-mediated chemoprotection enhances adaptation of E. coli PNP for herpes simplex virus-based glioma therapy.
    Bharara S; Sorscher EJ; Gillespie GY; Lindsey JR; Hong JS; Curlee KV; Allan PW; Gadi VK; Alexander SA; Secrist JA; Parker WB; Waud WR
    Hum Gene Ther; 2005 Mar; 16(3):339-47. PubMed ID: 15812229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced efficiency of prodrug activation therapy by tumor-selective replicating retrovirus vectors armed with the Escherichia coli purine nucleoside phosphorylase gene.
    Tai CK; Wang W; Lai YH; Logg CR; Parker WB; Li YF; Hong JS; Sorscher EJ; Chen TC; Kasahara N
    Cancer Gene Ther; 2010 Sep; 17(9):614-23. PubMed ID: 20467451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PNP anticancer gene therapy.
    Zhang Y; Parker WB; Sorscher EJ; Ealick SE
    Curr Top Med Chem; 2005; 5(13):1259-74. PubMed ID: 16305530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical evaluation of a prostate-targeted gene-directed enzyme prodrug therapy delivered by ovine atadenovirus.
    Wang XY; Martiniello-Wilks R; Shaw JM; Ho T; Coulston N; Cooke-Yarborough C; Molloy PL; Cameron F; Moghaddam M; Lockett TJ; Webster LK; Smith IK; Both GW; Russell PJ
    Gene Ther; 2004 Nov; 11(21):1559-67. PubMed ID: 15343359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and evaluation of 5'-modified nucleoside analogs as prodrugs for an E. coli purine nucleoside phosphorylase mutant.
    Parker WB; Allan PW; Ealick SE; Sorscher EJ; Hassan AE; Silamkoti AV; Fowler AT; Waud WR; Secrist JA
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):387-92. PubMed ID: 16247956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of Trichomonas vaginalis purine nucleoside phosphorylase to activate fludarabine in the treatment of solid tumors.
    Parker WB; Allan PW; Waud WR; Hong J; Gilbert-Ross M; Achyut BR; Joshi D; Behbahani T; Rab R; Ealick SE; Sorscher EJ
    Cancer Chemother Pharmacol; 2020 Mar; 85(3):573-583. PubMed ID: 31915968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of replication-competent retrovirus expressing Escherichia coli purine nucleoside phosphorylase increases the metabolism of the prodrug, fludarabine phosphate and suppresses the growth of bladder tumor xenografts.
    Kikuchi E; Menendez S; Ozu C; Ohori M; Cordon-Cardo C; Logg CR; Kasahara N; Bochner BH
    Cancer Gene Ther; 2007 Mar; 14(3):279-86. PubMed ID: 17218950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suicide gene/prodrug therapy for pancreatic adenocarcinoma by E. coli purine nucleoside phosphorylase and 6-methylpurine 2'-deoxyriboside.
    Deharvengt S; Wack S; Uhring M; Aprahamian M; Hajri A
    Pancreas; 2004 Mar; 28(2):E54-64. PubMed ID: 15028961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological activity of 2-fluoro adenine and 6-methyl purine nucleoside analogs as prodrugs for suicide gene therapy of cancer.
    Silamkoti AV; Allan PW; Hassan AE; Fowler AT; Sorscher EJ; Parker WB; Secrist JA
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):881-5. PubMed ID: 16248054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6-Methylpurine derived sugar modified nucleosides: Synthesis and evaluation of their substrate activity with purine nucleoside phosphorylases.
    Hassan AE; Abou-Elkhair RA; Parker WB; Allan PW; Secrist JA
    Bioorg Chem; 2016 Apr; 65():9-16. PubMed ID: 26745284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designer gene therapy using an Escherichia coli purine nucleoside phosphorylase/prodrug system.
    Bennett EM; Anand R; Allan PW; Hassan AE; Hong JS; Levasseur DN; McPherson DT; Parker WB; Secrist JA; Sorscher EJ; Townes TM; Waud WR; Ealick SE
    Chem Biol; 2003 Dec; 10(12):1173-81. PubMed ID: 14700625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.